Skip to main content

Ranganath Anil P.'s Form 4 filing

TransMedics Group, Inc.TMDX · filed Aug 9, 2024

Accession no.
0000950170-24-094809
Filed
Aug 9, 2024
Trade date
Jun 5-Aug 7, 2024
Filing delay
65 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $747.8K. It was filed 65 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Ranganath Anil P.CIK 0001980144Officer (See remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 5, 2024Common StockSSaleDisposed−703$135.21−$95,052.638,809Direct
Aug 7, 2024Common StockMOption exerciseAcquired+4,289$93.88+$402,651.3213,182Direct
Aug 7, 2024Common StockSSaleDisposed−4,289$152.20−$652,785.88,893Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 7, 2024Common StockMOption exerciseDisposed−4,289$0.00$010,420Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Remarks

Senior Vice President, General Counsel and Secretary

Read the full filing on SEC EDGAR (opens in a new tab)